Recent Advances in the Diagnosis and Prognosis of Lung Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 10 December 2025 | Viewed by 895
Special Issue Editor
Special Issue Information
Dear Colleagues,
Lung cancer persists as one of the most widespread and lethal malignancies globally, driving the urgent need for innovative diagnostic and prognostic strategies to improve survival and patient outcomes. This Special Issue spotlights cutting-edge research and technological advancements reshaping the field, with a dual emphasis on precision detection and personalized prognostication.
At the forefront of diagnosis, emerging imaging modalities, molecular biomarker discovery, and genomic profiling are revolutionizing early detection and diagnostic accuracy. These tools address critical challenges such as tumor heterogeneity and late-stage presentation, offering hope for timely intervention. Complementing these advances, artificial intelligence (AI)-driven predictive models and genomic signatures are redefining prognostic paradigms, enabling clinicians to stratify risk, predict therapeutic response, and tailor management plans to individual patients. By synthesizing contributions from leading researchers and clinicians, this issue provides a comprehensive examination of both current innovations and future trajectories in lung cancer care.
Prof. Dr. Naomi Takemura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- molecular biomarkers
- artificial intelligence
- early detection
- precision detection
- medical imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
